$EMBC Fraud Notification: Embecta Sued for Fraud Over Misrepresentations about its Insulin Pen Issues – Investors Notified to Contact BFA Law

Embecta Corp. faces a securities fraud class action lawsuit after its stock plummeted 57.8% on May 5, 2026, when the company revealed disappointing Q2 results and admitted to significant market softness in insulin pens and pen needles. Investors allege the company misrepresented the strength of its insulin pen portfolio prior to the announcement. The lead plaintiff deadline is August 17, 2026.